Milestone Pharmaceuticals Inc. cotiza a 0.81 USD y tiene una capitalización bursátil de $100M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines in the United States and Canada. It offers CARDAMYST (etripamil) nasal spray, a prescription medication for the conversion of acute symptomatic episodes of paroxysmal supraventricula…
| Periodo | 2026-08 | 2026-05 | 2026-03 | 2025-11 |
|---|---|---|---|---|
| Real | $-0.21 | $-0.20 | $-0.15 | $-0.12 |
| Estimado | $-0.19 | $0.19 | $-0.18 | $-0.17 |
| Sorpresa | -10.5% | -205.3% | +16.7% | +29.4% |
| Métrica | MIST | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | -4019.4% | -38.6% | -3980.8% |
| Net Margin | -4078.8% | -33.6% | -4045.2% |
| FCF Margin | -3191.7% | -13.9% | -3177.8% |
| ROE | -151.0% | -40.4% | -110.6% |
| ROA | -55.5% | -32.0% | -23.5% |
| Current Ratio | 8.01 | 2.84 | +5.17 |
| Debt / Equity | 1.37 | 0.28 | +1.09 |